SEOUL -- After successfully penetrating the European market, South Korean pharmaceutical company Celltrion has set its sights on a new target: China.
Companies
South Korean drugmaker Celltrion sets sights on China
Biosimilar specialist also shopping for subsidies to build overseas plant
Led by a former auto industry executive, Celltrion has gone from zero to $840 million in annual sales in 15 years. © Reuters
Read Next
Latest on Companies
